Anticholinergics for mucus
Anticholinergic agents in theory will reduce mucus production. This could inadvertently lead to a more sticky secretion in chronic bronchitis and CF patients. However in vivostudies point out that this anticholinergic activity is clinically ratherunimportant.
Nevertheless some patients do experience some dryness of mouth orthroat after inhalation of ipratropium.
See also: anticholinergics for lung.
Ipratropium can be used as supplementary therapy in hypersecretory diseases.
Extra info: Although ipratropium can be used as supplemental therapy for these patients, they provide little clinical utility.